Table 3.
Correlations between PUFA Levels and Clinical Parameters.
DGLA | AA | EPA | DHA | EPA/AA | Estimated D5D | |
---|---|---|---|---|---|---|
BMI | 0.316*** | 0.217** | -0.159* | -0.074 | -0.246*** | -0.166* |
Age | -0.260*** | -0.328*** | 0.324*** | 0.253*** | 0.454*** | 0.033 |
Waist circumference | 0.227*** | 0.165* | -0.088 | -0.003 | -0.152* | -0.109 |
ALT level | 0.270*** | 0.150* | -0.078 | 0.008 | -0.147* | -0.178** |
TGL | 0.362*** | 0.270*** | -0.044 | 0.234*** | -0.169* | -0.151* |
HbA1c level | -0.114 | 0.047 | -0.136* | -0.135 | -0.157* | 0.125 |
HOMA-IR | 0.367*** | 0.169* | -0.012 | 0.064 | -0.097 | -0.255*** |
Body fat percentage | 0.315** | 0.208 | -0.101 | 0.013 | -0.188 | -0.182 |
Skeletal mass index | 0.031 | 0.100 | -0.229* | -0.272* | -0.274* | 0.030 |
Spearman correlation coefficient (ρ) were used to evaluate correlations between variables. *p<0.05, **p<0.01, ***p<0.001. FUFA: polyunsaturated fatty acid, BMI: body mass index, ALT: alanine amino transferase, TGL: triglyceride, HbA1c: glycated hemoglobin, HOMA-IR: homeostatic model assessment of insulin resistance, DGLA: dihomo-γ-linolenic acid, AA: arachidonic acid, EPA: eicosapentaenoic acid, DHA: docosahexaenoic acid, D5D: Δ-5 desaturase